Drug Therapy No medical indication Duplicate therapy Non-drug therapy indicated Treating avoidable ADR Requires Different Drug ... McDonough RP, Doucette WR (2003). "Drug therapy management: an empirical report of drug therapy problems, pharmacists' ... A drug-therapy (related) problem can be defined as an event or circumstance involving drug treatment (pharmacotherapy) that ... Drug therapy problems (DTPs) (or drug related problems, DRPs) represent the categorization and definition of clinical problems ...
... is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to ... "Cardiovascular Drugs and Therapy". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2021. ...
... is a peer-reviewed medical journal covering research on drug design and development ...
Drugs granted breakthrough therapy designation (BTD) by the US Food and Drug Administration (FDA). Drugs may be listed more ... "CDER Breakthrough Therapy Designation Approvals Data as of December 31, 2022" (PDF). U.S. Food and Drug Administration (FDA). ... "Breakthrough Therapy Approvals". U.S. Food and Drug Administration (FDA). 2020-10-08. Archived from the original on 2023-06-11 ... "Breakthrough Therapy Approvals". U.S. Food and Drug Administration (FDA). 2020-10-08. Archived from the original on 2023-06-11 ...
"Drug Therapies". www.ata.org. 2015-03-20. Retrieved 2019-05-06. Henry; et al. (2007). Tinnitus Retraining Therapy: Clinical ... Music therapy, Counseling, Behavior therapy, Cognitive therapy, Alternative medicine). ... Tinnitus retraining therapy (TRT) is a form of habituation therapy designed to help people who experience tinnitus-a ringing, ... pharmacological - No drug has been approved by the U.S. Food and Drug Administration (FDA) for treating tinnitus. However, ...
Stege R, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette A (1988). "Single drug polyestradiol phosphate therapy in ... Feminizing hormone therapy, also known as transfeminine hormone therapy, is hormone therapy and sex reassignment therapy to ... Transgender portal Menopausal hormone therapy Androgen replacement therapy Masculinizing hormone therapy Hembree WC, Cohen- ... Wu JJ (18 October 2012). Comprehensive Dermatologic Drug Therapy E-Book. Elsevier Health Sciences. pp. 364-. ISBN 978-1-4557- ...
... may also be used to limit variation in drug concentration in the blood (i.e. between the peak drug levels and the trough drug ... Raehl CL (July 1986). "Endotracheal drug therapy in cardiopulmonary resuscitation". Clinical Pharmacy. 5 (7): 572-9. PMID ... Intravenous therapy (abbreviated as IV therapy) is a medical technique that administers fluids, medications and nutrients ... Many therapies are administered as a "bolus" or one-time dose, but they may also be administered as an extended infusion or ...
"Single drug polyestradiol phosphate therapy in prostatic cancer". American Journal of Clinical Oncology. 11 Suppl 2: S101-3. ... High-dose estrogen therapy (HDE) is a type of hormone therapy in which high doses of estrogens are given. When given in ... Hormone replacement therapy Estrogen deprivation therapy Hyperestrogenism Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen ... It has been found to result in estradiol levels of about 3,100 pg/mL at 3 months of therapy and 2,500 pg/mL at 6 months of ...
Marcotte, David; Avants, Kelly; Margolin, Arthur (2003). "Spiritual Self-Schema Therapy, Drug Abuse, and HIV". Journal of ... Spiritual self-schema therapy, sometimes referred to as 3-S Therapy, was developed at Yale University School of Medicine by S. ... Spiritual self-schema therapy is one such attempt. Spiritual self-schema therapy enables a cognitive shift from the habitual " ... therapy for reducing impulsivity in HIV-positive drug users". Journal of Clinical Psychology. 63 (10): 979-999. doi:10.1002/ ...
... includes drugs and surgery. The drugs are thrombolytics and fibrinolytics used in a process called ... Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994). "Indications for fibrinolytic therapy in suspected acute ... Thrombolytic therapy is indicated for the treatment of STEMI - if it can begin within 12 hours of the onset of symptoms, and ... Reperfusion therapy is a medical treatment to restore blood flow, either through or around, blocked arteries, typically after a ...
Drug therapy. There are speculations that if genetics plays a role in PEX, and if the specific genes involved can be identified ... that possibly drugs can be developed to counteract these mutations or their effects. But such drugs have not been developed as ... A further treatment is a type of laser therapy known as trabeculoplasty in which a high-energy laser beam is pointed at the ...
Type E for withdrawal adverse drug reactions, and Type F for failure of therapy as an adverse drug reaction. Adverse drug ... a drug and a disease two drugs Antagonism effects between either: a drug and a disease two drugs Various diseases, especially ... Alleged problems in the drug approval process Classification of Pharmaco-Therapeutic Referrals Drug therapy problems ... Textbook of adverse drug reactions. Oxford: Oxford University Press. p. 10. Aronson JK (2002). "Drug therapy". In Haslett C, ...
"Recovery With Purpose: Occupational Therapy and Drug and Alcohol Abuse". American Occupational Therapy Association. Retrieved ... Use dmy dates from September 2023, Occupational therapy, Drug rehabilitation). ... "Telehealth Opportunities in Occupational Therapy Through the Affordable Care Act". The American Journal of Occupational Therapy ... While SUD can affect a client's participation in therapy and ability to follow recommendations, occupational therapists are ...
Grover, Natalie (28 Apr 2016). "Acadia drug approval could clear way for Axovant dementia therapy". Reuters. "Axovant Reports ... Sio Gene Therapies (formerly known as Axovant Gene Therapies) was a clinical-stage pharmaceutical company that developed gene ... In November 2020, Axovant rebranded as Sio Gene Therapies. On April 5, 2023, the shareholders of Sio Gene Therapies voted to ... We're not a vant': Axovant seeks to forget the past as the company rebrands to Sio Gene Therapies". Endpoints News. "Sio Gene ...
"Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery". Advanced Drug Delivery Reviews. 63 (9): ... such as monoclonal antibodies and liposome-encapsulated drugs. Cellular uptake of certain small molecule drugs is also ... Hyperthermia therapy (or hyperthermia, or thermotherapy) is a type of medical treatment in which body tissue is exposed to ... Hot chemotherapy drugs are pumped directly into the peritoneal cavity to kill the cancer cells. Whole-body hyperthermia heats ...
21-. ISBN 978-3-7091-5694-0. Basic Sex Hormone Therapy. Schering A.G. 1962. p. 96. Current Medicine and Drugs. 1962. p. 40. ... "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018. Engel J, Kleemann A ... Current Drug Therapy. 1 (2): 211-219. doi:10.2174/157488506776930923. Whitaker A, Gilliam M (2014). Contraception for ... Progesterone is used as part of hormone replacement therapy in people who have low progesterone levels, and for other reasons. ...
Drug Therapy Topics. University of Washington Medical Center. Retrieved 25 December 2013. (Articles with short description, ... ATC/DDD Index Research, Center for Drug Evaluation and (2020-02-13). "FDA requests the withdrawal of the weight-loss drug ... Drugs of this class are frequently stimulants of the phenethylamine family, related to amphetamine.[citation needed] The German ... Handbook of Non Drug Intervention (HANDI) Project Team (2013). "Pre-meal water consumption for weight loss". Australian Family ...
Giuffre I (2007). "Ibopamine stimulates α-adrenergic receptors and D1 dopaminergic receptors in the eye". Current Drug Therapy ... Rajfer SI, Rossen JD, Douglas FL, Goldberg LI, Karrison T (April 1986). "Effects of long-term therapy with oral ibopamine on ... Metra M, Missale C, Spano PF, Cas LD (May 1995). "Dopaminergic drugs in congestive heart failure: hemodynamic and ... Ibopamine is a sympathomimetic drug, designed as a prodrug of epinine (deoxyepinephrine or N-methyldopamine), used in ...
Current Drug Therapy. 1 (2): 211-219. doi:10.2174/157488506776930923. ISSN 1574-8855. Whitaker, Amy; Gilliam, Melissa (2014). ... 342-. ISBN 978-1-4698-2604-2. Quigley MM (August 1986). "Drugs in the treatment of female infertility. Recent advances". Drugs ... Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Agents. Vol. II. ... Pharmacology of the endocrine system and related drugs: progesterone, progestational drugs and antifertility agents. Pergamon ...
Current Drug Therapy. 1 (1): 85-89. doi:10.2174/157488506775268506. Huang YF, Pryor ME, Mather LE, Veering BT (April 1998). " ... Drugs with non-standard legal status, Articles with changed EBI identifier, Multiple chemicals in Infobox drug, Chemicals using ... The drug typically starts taking effect within 15 minutes and can last up to 16 hours depending on factors such as site of ... For example, drugs with a high pKa, such as that of levobupivacaine, tend to be their ionised form under physiological state, ...
Antipsychotic drugs are used to treat dementia only if non-drug therapies have not worked, and the person's actions threaten ... sometimes antipsychotic drugs are considered as a therapy in response. These drugs have risky adverse effects, including ... Psychological therapies for dementia include some limited evidence for reminiscence therapy (namely, some positive effects in ... Commission de la transparence (June 2012). "Drugs for Alzheimer's disease: best avoided. No therapeutic advantage" [Drugs for ...
No authors listed] (2001). "Linezolid: First of a New Drug Class for Gram-Positive Infections". Drugs & Therapy Perspectives. ... "Drug Approval Package: Zyvox". FDA Center for Drug Evaluation and Research. 20 November 2001. Archived from the original on 10 ... Raviña E (2011). "Vinca alkaloids". The evolution of drug discovery: From traditional medicines to modern drugs. John Wiley & ... "Linezolid for the treatment of drug-resistant infections". Expert Review of Anti-infective Therapy. 6 (6): 825-48. doi:10.1586/ ...
Drug Therapy Series. The New England Journal of Medicine 339:746-754, 1998 Parrish-Novak J, Dillon SR, Nelson A, Hammond A, ... and enhances erythroid recovery after myelosuppressive therapy. J. Clin. Invest. 96:1683-1687, 1995. Fero ML, Rivkin M, Tasch M ... runs several projects to understand the physiology of megakaryotic developments and the tools necessary to perform gene therapy ...
Current Drug Therapy. 1 (2): 211-219. doi:10.2174/157488506776930923. Unfer V, Casini ML, Marelli G, Costabile L, Gerli S, Di ... Unlisted Drugs. Unlisted Drugs. 1976. p. 360. The Belfast Gazette. H.M. Stationery Office. January 1977. p. 158. Negwer M (1978 ... "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: 019781". Food and Drug Administration. 2 July ... "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations: 022057". Food and Drug Administration. 2 July ...
a brief history of immunosuppressive drugs. Accessed on 21 August 2005. Papich M (2001). "Immunosuppressive drug therapy". ... Immunosuppressive drugs are used in immunosuppressive therapy to: Prevent the rejection of transplanted organs and tissues (e.g ... Immunosuppressive drugs can be classified into five groups:[citation needed] glucocorticoids cytostatics antibodies drugs ... Immunosuppressive drugs, also known as immunosuppressive agents, immunosuppressants and antirejection medications, are drugs ...
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 ... Infobox drug with local INN variant, Drugs with non-standard legal status, ECHA InfoCard ID from Wikidata, Drug has EMA link, ... There is no data on use in pregnant women, but the drug does cross the placenta and is excreted in breast milk. The drug should ... "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 ...
Drugs & Therapy Perspectives. 22 (6): 1-6. doi:10.2165/00042310-200622060-00001. ISSN 1172-0360. S2CID 72178165. v t e ( ... A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential". Drugs. 46 (4): 720-45. doi: ... Drugs with no legal status, Macrolide antibiotics, Propionate esters, Acetate esters, All stub articles, Antibiotic stubs). ...
However, with regard to this drug's promise for the therapy of advanced cancers, it is unclear whether the inhibition of COX-2 ... "Will the promise of the COX-2 selective NSAIDs come to fruition?". Drugs & Therapy Perspectives. Adis International Limited. 17 ... and other members of this drug class. After several COX-2-inhibiting drugs were approved for marketing, data from clinical ... preclinical development of novel anticancer drugs". Expert Opinion on Investigational Drugs. 17 (2): 197-208. doi:10.1517/ ...
Drugs & Therapy Perspectives. 29 (1): 1-6. doi:10.1007/s40267-012-0005-9. ISSN 1172-0360. S2CID 71591520. Passeri T, Champagne ... "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 9 December 2016. Croxatto HB ( ... Drugs with non-standard legal status, ECHA InfoCard ID from Wikidata, Drug has EMA link, Articles containing unverified ... but the FDATooltip Food and Drug Administration rejected the NDATooltip New Drug Application for Zoely in 2011 and NOMAC ...
Current Drug Therapy. epub ahead of print. doi:10.2174/1574885518666230710122712. Soleimani V, Delghandi PS, Moallem SA, Karimi ... Wu JW, Lin LC, Tsai TH (2009). "Drug-drug interactions of silymarin on the perspective of pharmacokinetics". Journal of ... For approved drug preparations and parenteral applications in the treatment of Amanita mushroom poisoning, the water-soluble ... Saller R, Meier R, Brignoli R (2001). "The use of silymarin in the treatment of liver diseases". Drugs. 61 (14): 2035-63. doi: ...